EP2467399 - Purification of vWF for increased removal of non-lipid enveloped viruses [Right-click to bookmark this link] | |||
Former [2012/26] | PURIFICATION OF VWF FOR INCREASED REMOVAL OF NON-LIPID ENVELOPED VIRUSES | ||
[2015/19] | Status | Patent maintained as amended Status updated on 30.12.2022 Database last updated on 24.08.2024 | Most recent event Tooltip | 02.08.2024 | Lapse of the patent in a contracting state New state(s): PL | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Baxalta Incorporated 1200 Lakeside Drive Bannockburn, IL 60015 / US | For all designated states Baxalta GmbH Zaehlerweg 4 6300 Zug / CH | [2023/04] |
Former [2015/43] | For all designated states Baxalta Incorporated 1200 Lakeside Drive Bannockburn, IL 60015 / US | ||
For all designated states Baxalta GmbH Thurgauerstrasse 130 8152 Glattpark, Opfikon / CH | |||
Former [2012/26] | For all designated states Baxter International Inc. One Baxter Parkway Deerfield, IL 60015 / US | ||
For all designated states Baxter Healthcare S.A. Thurgauerstrasse 130 8152 Glattpark (Opfikon) / CH | Inventor(s) | 01 /
MITTERER, Artur Schwarzeckerweg 10 A-2304 Orth/Donau / AT | 02 /
HASSLACHER, Meinhard Vorgartenstrasse 221/1/7 A-1020 Vienna / AT | 03 /
MAYER, Christa Bahnhofstrasse 2 A-2412 Wolfsthal / AT | [2012/26] | Representative(s) | Alt, Michael, et al Bird & Bird LLP Maximiliansplatz 22 80333 München / DE | [2015/46] |
Former [2012/26] | Alt, Michael, et al Bird & Bird LLP Pacellistraße 14 80333 München / DE | Application number, filing date | 10747134.4 | 20.08.2010 | [2015/46] | WO2010US46180 | Priority number, date | US20090235570P | 20.08.2009 Original published format: US 235570 P | [2012/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011022657 | Date: | 24.02.2011 | Language: | EN | [2011/08] | Type: | A1 Application with search report | No.: | EP2467399 | Date: | 27.06.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.02.2011 takes the place of the publication of the European patent application. | [2012/26] | Type: | B1 Patent specification | No.: | EP2467399 | Date: | 11.11.2015 | Language: | EN | [2015/46] | Type: | B2 New European patent specification | No.: | EP2467399 | Date: | 01.02.2023 | Language: | EN | [2023/05] | Search report(s) | International search report - published on: | EP | 24.02.2011 | Classification | IPC: | C07K14/755 | [2015/23] | CPC: |
C07K14/755 (EP,CN,US);
A61K38/00 (EP,US);
C07K1/18 (US)
|
Former IPC [2012/26] | C07K14/755, A61K38/36 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/26] | Title | German: | Aufreinigung von vWF für erhöhte Entfernung von nichtlipiden eingehüllten Viren | [2023/04] | English: | Purification of vWF for increased removal of non-lipid enveloped viruses | [2015/19] | French: | Purification du vWF pour une meilleure élimination des virus à enveloppe non lipidique | [2015/19] |
Former [2012/26] | AUFRENIGUNG VON VWF FÜR ERHÖHTE ENTFERNUNG VON NICHTLIPIDEN EINGEHÜLLTEN VIREN | ||
Former [2012/26] | PURIFICATION OF VWF FOR INCREASED REMOVAL OF NON-LIPID ENVELOPED VIRUSES | ||
Former [2012/26] | PURIFICATION DU VWF POUR UNE MEILLEURE ÉLIMINATION DES VIRUS À ENVELOPPE NON LIPIDIQUE | Entry into regional phase | 15.03.2012 | National basic fee paid | 15.03.2012 | Designation fee(s) paid | 15.03.2012 | Examination fee paid | Examination procedure | 15.03.2012 | Examination requested [2012/26] | 22.10.2012 | Amendment by applicant (claims and/or description) | 11.02.2013 | Despatch of a communication from the examining division (Time limit: M06) | 20.08.2013 | Reply to a communication from the examining division | 11.08.2014 | Despatch of a communication from the examining division (Time limit: M04) | 17.12.2014 | Reply to a communication from the examining division | 15.05.2015 | Communication of intention to grant the patent | 23.09.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 23.09.2015 | Fee for grant paid | 23.09.2015 | Fee for publishing/printing paid | 05.10.2015 | Information about intention to grant a patent | 05.10.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.02.2013 | Opposition(s) | Opponent(s) | 01
11.08.2016
17.08.2016
ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
Former [2016/38] | |||
Opponent(s) | 01
11.08.2016
17.08.2016
ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative D Young & Co LLP 120 Holborn London EC1N 2DY / GB | 28.09.2016 | Invitation to proprietor to file observations on the notice of opposition | 01.02.2017 | Reply of patent proprietor to notice(s) of opposition | 13.02.2018 | Date of oral proceedings | 09.07.2018 | Despatch of minutes of oral proceedings | 11.07.2018 | Despatch of interlocutory decision in opposition | 15.06.2021 | Legal effect of interlocutory decision in opposition | 20.09.2022 | Despatch of communication that the patent will be maintained as amended | 20.12.2022 | Fee for printing new specification paid | Appeal following opposition | 17.09.2018 | Appeal received No. T2437/18 | 15.06.2021 | Result of appeal procedure: appeal of the proprietor was rejected | 20.07.2022 | Despatch of the decision of the Board of Appeal | 15.06.2021 | Date of oral proceedings | Fees paid | Renewal fee | 27.08.2012 | Renewal fee patent year 03 | 27.08.2013 | Renewal fee patent year 04 | 27.08.2014 | Renewal fee patent year 05 | 27.08.2015 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 11.11.2015 | BG | 11.11.2015 | CY | 11.11.2015 | CZ | 11.11.2015 | EE | 11.11.2015 | HR | 11.11.2015 | LT | 11.11.2015 | LV | 11.11.2015 | MC | 11.11.2015 | MK | 11.11.2015 | PL | 11.11.2015 | RO | 11.11.2015 | SI | 11.11.2015 | SK | 11.11.2015 | SM | 11.11.2015 | GR | 12.02.2016 | IS | 11.03.2016 | LU | 20.08.2016 | MT | 31.08.2016 | [2024/36] |
Former [2023/35] | AL | 11.11.2015 | |
BG | 11.11.2015 | ||
CY | 11.11.2015 | ||
CZ | 11.11.2015 | ||
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
MK | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
MT | 31.08.2016 | ||
Former [2018/46] | AL | 11.11.2015 | |
BG | 11.11.2015 | ||
CY | 11.11.2015 | ||
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
MK | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
MT | 31.08.2016 | ||
Former [2018/38] | BG | 11.11.2015 | |
CY | 11.11.2015 | ||
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
MK | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
MT | 31.08.2016 | ||
Former [2018/34] | CY | 11.11.2015 | |
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
MK | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
MT | 31.08.2016 | ||
Former [2018/29] | CY | 11.11.2015 | |
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
MK | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
Former [2018/10] | EE | 11.11.2015 | |
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
Former [2017/44] | DK | 11.11.2015 | |
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
LU | 20.08.2016 | ||
Former [2017/23] | DK | 11.11.2015 | |
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
MC | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/49] | DK | 11.11.2015 | |
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
RO | 11.11.2015 | ||
SI | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/39] | DK | 11.11.2015 | |
EE | 11.11.2015 | ||
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
RO | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/38] | EE | 11.11.2015 | |
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
RO | 11.11.2015 | ||
SK | 11.11.2015 | ||
SM | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/36] | EE | 11.11.2015 | |
HR | 11.11.2015 | ||
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
RO | 11.11.2015 | ||
SK | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/25] | HR | 11.11.2015 | |
LT | 11.11.2015 | ||
LV | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/24] | HR | 11.11.2015 | |
LT | 11.11.2015 | ||
GR | 12.02.2016 | ||
IS | 11.03.2016 | ||
Former [2016/23] | HR | 11.11.2015 | |
LT | 11.11.2015 | ||
IS | 11.03.2016 | ||
Former [2016/22] | LT | 11.11.2015 | |
IS | 11.03.2016 | ||
Former [2016/20] | LT | 11.11.2015 | Cited in | International search | [A]US6465624 (FISCHER BERNHARD [AT], et al) [A] 13-15 * the whole document * * abstract * * column 3, line 45 - line 54 * * column 4, line 59 - line 62 * * column 6, line 11 - line 22 * * column 6, line 45 - line 52 * * column 11, line 14 - column 12, line 32; example 3 * * claims 1, 8 * * claim 13 *; | [I] - CAMERON R ET AL, "The removal of model viruses, poliovirus type 1 and canine parvovirus, during the purification of human albumin using ion-exchange chromatographic procedures.", BIOLOGICALS : JOURNAL OF THE INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION DEC 1997 LNKD- PUBMED:9467035, (199712), vol. 25, no. 4, doi:10.1006/biol.1997.0115, ISSN 1045-1056, pages 391 - 401, XP002610211 [I] 1-12 * the whole document * * abstract * * page 392, column r, paragraph 1 * * "Discussion"; page 399 - page 400 * DOI: http://dx.doi.org/10.1006/BIOL.1997.0115 | [I] - Chapter 9, "Ion Exchange Chromatography", Chapter 9, Bollag DM, Rozycki MD, Edelstein SJ, Protein Methods (2nd edition), New York, NY, Wiley-Liss, Inc., (1996), XP002609616 [I] 1-12 * page 231 - page 239 * | [A] - CHANDRA SUDHISH ET AL, "Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products.", THROMBOSIS RESEARCH 1 MAR 2002 LNKD- PUBMED:12062540, (20020301), vol. 105, no. 5, doi:10.1016/S0049-3848(02)00044-0, ISSN 0049-3848, pages 391 - 400, XP002610212 [A] 13-15 * the whole document * * abstract * * section 3.2. "Purification steps that reduce viral contamination"; page 393 * DOI: http://dx.doi.org/10.1016/S0049-3848(02)00044-0 | [A] - SOLHEIM ET AL, "Pathogen reduction of blood components", TRANSFUSION AND APHERESIS SCIENCE, ELSEVIER SCIENCE, LONDON, GB, vol. 39, no. 1, doi:DOI:10.1016/J.TRANSCI.2008.05.003, ISSN 1473-0502, (20080801), pages 75 - 82, (20080703), XP023613846 [A] 13-15 * the whole document * * abstract * DOI: http://dx.doi.org/10.1016/j.transci.2008.05.003 | [A] - PROWSE ET AL, "Properties of Pathogen-Inactivated Plasma Components", TRANSFUSION MEDICINE REVIEWS, GRUNE AND STRATTON, ORLANDO, FL, US, vol. 23, no. 2, doi:DOI:10.1016/J.TMRV.2008.12.004, ISSN 0887-7963, (20090401), pages 124 - 133, (20090320), XP026017877 [A] 13-15 * the whole document * * abstract * * table 1 * * table 4 * DOI: http://dx.doi.org/10.1016/j.tmrv.2008.12.004 | by applicant | US3941763 | WO8606096 | US7005502 | US2006160948 | - LEYTE ET AL., BIOCHEM. J., (1991), vol. 274, pages 257 - 261 | - RUGGERI Z.A.; WARE, J., FASEB J., (1993), pages 308 - 316 | - "Guideline on Viral Safety Evaluations of Biotechnology Products", FEDERAL REGISTER, (1998), vol. 63, no. 185, pages 51074 - 51084 | - LANKHOF ET AL., THROMB. HAEMOST., (1997), vol. 77, pages 1008 - 1013 | - PIETU ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1989), vol. 164, pages 1339 - 1347 | - MERRIFIELD, Chem. Polypeptides, (1973), pages 335 - 61 | - MERRIFIELD, J. AM. CHEM. SOC., (1963), vol. 85, page 2149 | - DAVIS ET AL., BIOCHEM. INTL., (1985), vol. 10, pages 394 - 414 | - FINN ET AL., The Proteins (3rd ed.), (1976), vol. 2, pages 105 - 253 | - ERICKSON ET AL., The Proteins(3rd ed.), (1976), vol. 2, pages 257 - 527 | - FERNANDES; GREGORIADIS, BIOCHIM. BIOPHYS. ACTA, (1997), vol. 1341, pages 26 - 34 | - SAENKO ET AL., HAEMOPHILIA, (2006), vol. 12, pages 42 - 51 | - MIGNEAULT ET AL., BIOTECHNIQUES, (2004), vol. 37, pages 790 - 796 | - SAMBROOK ET AL., Molecular Cloning, COLD SPRING HARBOR LABORATORY PRESS, (1989), pages 9.47 - 9.51 | US19900559509 | Opposition | EP0934748 | US2002058625 | US6465624 | - JOHNSTON ADCOCK;, Biotechnology and Genetic Engineering Reviews, (20000000), vol. 17 | - CAMERON et al., "the removal of model viruses poliovirus type 1 and canine parvovirus", Biologicals, (19970000), vol. 25, pages 391 - 401, XP002610211 DOI: http://dx.doi.org/10.1006/BIOL.1997.0115 | - 3.9 Characterization, purfication and determination of protein structure and organization, Textbook of Biochemistry with Clinical Correlations, Wiley, pages 117 - 118, XP055385074 | - CAMERON et al., "the removal of model viruses poliovirus type 1 and canine parvovirus", Biologicals, (19970000), vol. 25, pages 391 - 401 | - Exhibit 1: experimental study relating to example 3 of D2 | - Pharmacia LKB Biotechnology AB, 1991. Ion exchange chromatography principles and methods (3rd edition) Pharmacia, Uppsala, Sweden | - Declaration 12 4.2017 relating to the experimental study of D07 | - Declaration 23.11.2017 relating to an experimental study relating to example 3 of D2 | - Declaration Piers Acland QC relating to experimental study relating to example 3 of D2 |